1379510-15-2Relevant academic research and scientific papers
A general, enantioselective synthesis of protected morpholines and piperazines
O'Reilly, Matthew C.,Lindsley, Craig W.
, p. 2910 - 2913 (2012)
A short, high yielding protocol has been developed for the enantioselective and general synthesis of C2-functionalized, benzyl protected morpholines and orthogonally N,N′-protected piperazines from a common intermediate.
A general, enantioselective synthesis of 2-substituted thiomorpholines and thiomorpholine 1,1-dioxides
Reed, Carson W.,Lindsley, Craig W.
supporting information, (2019/09/10)
In the course of our drug discovery programs, we had need to access chiral, 2-substituted thiomorpholines and their oxidized congeners, thiomorpholine 1,1-dioxides. Here, we disclose a high-yielding, general protocol for the enantioselective synthesis of
Discovery and characterization of ML398, a potent and selective antagonist of the D4 receptor with in vivo activity
Berry, Cynthia B.,Bubser, Michael,Jones, Carrie K.,Hayes, John P.,Wepy, James A.,Locuson, Charles W.,Daniels, J. Scott,Lindsley, Craig W.,Hopkins, Corey R.
supporting information, p. 1060 - 1064 (2014/12/10)
Herein, we report the structure-activity relationship of a chiral morpholine-based scaffold, which led to the identification of a potent and selective dopamine 4 (D4) receptor antagonist. The 4-chlorobenzyl moiety was identified, and the compound was designated an MLPCN probe molecule, ML398. ML398 is potent against the D4 receptor with IC50 = 130 nM and Ki = 36 nM and shows no activity against the other dopamine receptors tested (>20 μM against D1, D2S, D2L, D3, and D5). Further in vivo studies showed that ML398 reversed cocaine-induced hyperlocomotion at 10 mg/kg.
